Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months throu...
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights:•Safety and immunogenicity of IIV4-HD was evaluated in USA and Canadian children 6 mos.-17 yrs. of age. •Three dose formulations of IIV4-HD (30 45, and 60 µg HA/strain/dose) were safe and well tolerated. •IIV4-HD 60 µg HA/strain/dose formulation generated higher immunogenicity compared to IIV4-SD. •Highest GMT ratios seen in children 6–3...
Alternative Titles
Full title
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2524302923
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2524302923
Other Identifiers
ISSN
0264-410X,1873-2518
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2021.02.014
